Anti-SARS-CoV-2 Envelope Protein Antibody (A283824)

Anti-SARS-CoV-2 Envelope Protein Antibody

Rabbit polyclonal antibody to SARS-CoV-2 Envelope Protein.

This antibody recognises envelope small membrane protein, also known as sM protein and E.Human coronaviruses are pathogens that can cause severe respiratory tract infections. SARS-CoV-2 is a novel human coronavirus characterized in 2020, and causes "coronavirus disease 2019" or "COVID-19". The four main structural proteins of SARS-CoV-2 are the spike (S) glycoprotein, the membrane (M) matrix protein, the nucleocapsid (N) protein, and the envelope (E) protein. The envelope protein plays a role in compromising the integrity of host membranes and forming membranous compartments in which the virus to replicate. It forms a homopentameric cation channel which mediates the budding and release of progeny viruses and activates the host inflammasome. Deletion of the envelope protein attenuates some coronaviruses, and the envelope protein has been suggested as a potential drug and vaccine target.

IHC-P, ELISA, IF

ELISA: 2,000 ng/ml - 32 ng/ml, IF: 3 µg/ml - 2 µg/ml, IHC-P: 3 µg/ml - 2 µg/ml

Viral

A peptide corresponding to 10 amino acids near the N-terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein. The immunogen is located within the first 50 amino acids of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope.

Rabbit

Polyclonal

IgG

Unconjugated

1 mg/ml

Liquid

Supplied in Phosphate Buffered Saline with 0.02% Sodium Azide.

Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.

Rabbit anti SARS-CoV-2 envelope antibody recognizes envelope small membrane protein, also known as sM protein and E.Human coronaviruses are pathogens that can cause severe respiratory tract infections. SARS-CoV-2 is a novel human coronavirus characterized in 2020, and causes "coronavirus disease 2019" or "COVID-19" (Xu et al. 2020). The four main structural proteins of SARS-CoV-2 are the spike (S) glycoprotein, the membrane (M) matrix protein, the nucleocapsid (N) protein, and the envelope (E) protein (Duart et al. 2020). The envelope protein plays a role in compromising the integrity of host membranes and forming membranous compartments in which the virus to replicate (Mukherjee et al. 2020). It forms a homopentameric cation channel which mediates the budding and release of progeny viruses and activates the host inflammasome. Deletion of the envelope protein attenuates some coronaviruses, and the envelope protein has been suggested as a potential drug and vaccine target (Mandala et al. 2020).